Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus
- PMID: 17169097
- DOI: 10.1111/j.1346-8138.2006.00203.x
Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus
Abstract
Discoid lupus erythematosus (DLE), a cutaneous form of lupus erythematosus, is characterized as atrophic and scaly erythema and the lesions are often refractory to a wide range of topical or systemic therapies. Herein, we present four cases of DLE that were successfully treated with topical tacrolimus. Tacrolimus ointment (0.1%) was applied to DLE lesions twice daily and the erythematous plaques readily diminished after 4-8 weeks. Adverse effects, such as burning sensation or irritations, were not observed. These results indicate that topical tacrolimus might be an effective and alternative treatment to control DLE.
Similar articles
-
Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.Clin Exp Dermatol. 2009 Oct;34(7):776-80. doi: 10.1111/j.1365-2230.2008.03138.x. Epub 2009 May 18. Clin Exp Dermatol. 2009. PMID: 19456797 Clinical Trial.
-
Pimecrolimus 1% cream for cutaneous lupus erythematosus.J Am Acad Dermatol. 2004 Sep;51(3):407-10. doi: 10.1016/j.jaad.2004.01.044. J Am Acad Dermatol. 2004. PMID: 15337984 Clinical Trial.
-
Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.Rheumatology (Oxford). 2004 Nov;43(11):1383-5. doi: 10.1093/rheumatology/keh325. Epub 2004 Jul 20. Rheumatology (Oxford). 2004. PMID: 15266063 Clinical Trial.
-
Granuloma faciale successfully treated with topical tacrolimus.Australas J Dermatol. 2009 Aug;50(3):217-9. doi: 10.1111/j.1440-0960.2009.00543.x. Australas J Dermatol. 2009. PMID: 19659988 Review.
-
The use of topical calcineurin inhibitors in lupus erythematosus: an overview.J Eur Acad Dermatol Venereol. 2008 Jan;22(1):1-6. doi: 10.1111/j.1468-3083.2007.02427.x. Epub 2007 Nov 12. J Eur Acad Dermatol Venereol. 2008. PMID: 18005117 Review.
Cited by
-
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.Biologics. 2011;5:21-31. doi: 10.2147/BTT.S9806. Epub 2011 Feb 14. Biologics. 2011. PMID: 21383913 Free PMC article.
-
Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.J Clin Aesthet Dermatol. 2013 Jan;6(1):27-38. J Clin Aesthet Dermatol. 2013. PMID: 23320123 Free PMC article.
-
Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases.Mediators Inflamm. 2012;2012:563709. doi: 10.1155/2012/563709. Epub 2012 Nov 1. Mediators Inflamm. 2012. PMID: 23258954 Free PMC article. Review.
-
Topical calcineurin inhibitors in systemic lupus erythematosus.Ther Clin Risk Manag. 2010 Apr 15;6:95-101. doi: 10.2147/tcrm.s3193. Ther Clin Risk Manag. 2010. PMID: 20421909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical